Lakewood-Amedex

Infectious Diseases: The Challenge of the 21st Century

Home

Company Overview

Management

Board of Directors

Products & Pipeline

Nubiotics

HUS Program

nRNA Technology

News & Publications

Press Releases

Related News Articles

Intellectual Property

Investor Relations

Investor News

Contact Us

Press Releases

January 27, 2011

LAKEWOOD-AMEDEX INC. RECEIVES NOTICE OF ALLOWANCE ON THREE US PATENT APPLICATIONS RELATING TO TREATMENT OF HEMOLYTIC UREMIC SYNDROME


August 27, 2009

LAKEWOOD-AMEDEX INC. TO DEVELOP BROAD SPECTRUM INFLUENZA DRUG TO INCLUDE H1N1 AND H5N1 TYPE A STRAINS


March 10, 2009

LAKEWOOD-AMEDEX INC. APPOINTS WILLIAM J. ROBISON, FORMER EXECUTIVE VICE PRESIDENT OF PFIZER, AS BOARD MEMBER


 


Document
Document
Document

March 28, 2007

AMEDEX THERAPEUTICS, INC. IS ISSUED NUBIOTICS PATENT


February 1, 2007

NU PHARMAS, INC. ACQUIRES RENAISSANCE NUTRACEUTICALS AND APPOINTS STEVE PARKINSON PRESIDENT AND CEO









Document
Document